Every 10-Q that XCEL BRANDS INC. (XELB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow XELB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XELB filings page.
Xcel Brands, Inc. reported another quarterly loss and highlighted liquidity risks. For the three months ended June 30, 2026, net licensing revenue was $1.12 million, down from $1.32 million a year earlier, and net loss attributable to stockholders was $2.48 million, compared with $3.99 million.
For the first six months of 2026, revenue was $2.27 million versus $2.65 million and net loss was $4.97 million versus $6.79 million. Cash and cash equivalents were $0.40 million at June 30, 2026, against total debt (term loans and senior secured notes) with a net carrying amount of $12.09 million. Management states there is substantial doubt about the company’s ability to meet obligations within 12 months despite April 2026 actions, including selling the Judith Ripka brand for $2.30 million cash plus an earn-out and refinancing part of its term loan via 12.5% senior secured notes.
Results are heavily dependent on key relationships: the Halston master license generated 57% of current-quarter revenue, and Qurate agreements provided 27%. Adjusted EBITDA for the quarter was $(0.48) million, and non-GAAP net loss was $1.29 million, or $(0.21) per diluted share.
Xcel Brands, Inc. reports Q1 2026 results showing continued losses and tight liquidity. Net licensing revenue was $1.14 million, down from $1.33 million a year earlier, and net loss was $2.49 million versus $2.80 million. Unrestricted cash fell to $0.18 million at March 31, 2026 against $12.59 million of term loan debt, and management states there is substantial doubt about the company’s ability to meet obligations within twelve months. Xcel refinanced part of its term loan in April 2026 with $2.60 million of new 12.5% senior secured notes and used restricted cash to repay $1.00 million of debt, and sold the Judith Ripka brand for $2.30 million plus potential earn-outs. Non-GAAP net loss was $1.39 million and Adjusted EBITDA was a loss of $0.70 million, reflecting a still-challenged but slightly improved loss profile.
Xcel Brands, Inc. reported weaker results for the quarter ended September 30, 2025. Net revenue fell to $1.1 million from $1.9 million a year earlier as licensing revenue declined and product sales were eliminated. The company posted a net loss attributable to stockholders of $7.9 million, compared with a $9.2 million loss in the prior-year quarter, driven largely by a $5.5 million non‑cash impairment tied to its Isaac Mizrahi (IM Topco) investment and ongoing operating losses.
Total assets declined to $40.5 million from $53.8 million at year-end 2024, while stockholders’ equity decreased to $16.6 million. Term loan debt (including paid-in-kind interest) rose to $12.5 million, and the company used $5.2 million of cash in operating activities over nine months, partially offset by $6.4 million of financing inflows from new debt and about $2.0 million of equity offerings. Management disclosed that recurring losses, cash burn, and limited liquidity create substantial doubt about the company’s ability to continue as a going concern, even after April 2025 debt refinancing and an August 2025 public offering and private placement.
Xcel Brands, Inc. reported details in its Form 10-Q including a 1-for-10 reverse stock split, consolidation of certain joint ventures, brand licensing activity, and debt refinancings. The company described owned and co-branded labels (Halston, Judith Ripka, C Wonder) and several collaborations launching in 2025–2026. It consolidated a 50% entity (Longaberger Licensing, LLC) as a variable interest entity and accounts for a noncontrolling interest. The filing discloses multiple term loans and a delayed draw facility used to repay prior debt, issuance and allocation of warrants related to these financings, and associated debt extinguishment costs. It also discloses certain collateral and lease terms, option and warrant reserves, and limited stock-based compensation activity.